Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
US FDA accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
-
AstraZeneca to highlight its commitment to blood cancers at the 2017 American Society of Hematology Annual Meeting
-
Tudorza reduces exacerbations and demonstrates cardiovascular safety in COPD patients
-
The European Medicines Agency accepts regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer
-
AstraZeneca makes regulatory submission for Tagrisso in 1st-line EGFR-mutated non-small cell lung cancer in Japan
-
AstraZeneca and Chinese Future Industry Investment Fund establish joint venture to develop new medicines in China
-
Faslodex receives US FDA approval for the treatment of advanced breast cancer in combination with abemaciclib
-
Fasenra (benralizumab) receives US FDA approval for severe eosinophilic asthma
-
Benralizumab receives positive EU CHMP opinion for severe, uncontrolled eosinophilic asthma
-
Year-To-Date and Q3 2017 Results
Latest articles and press releases
All of our latest press releases and articles are available to explore
